Login / Signup

Direct-acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta-analysis.

Jiaye LiuBuyun MaWanlu CaoMeng LiWichor M BramerMaikel P PeppelenboschMaikel P Peppelenbosch
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
Direct-acting antiviral treatment is highly effective and well-tolerated in liver transplant recipients with recurrent GT1 HCV infection.
Keyphrases
  • hepatitis c virus infection
  • hepatitis c virus
  • hiv infected
  • smoking cessation
  • antiretroviral therapy